Surgical Aortic Valve Replacement (SAVR)
Treatment for Non-rheumatic calcific aortic valve disease
Effectiveness
92%
Safety Score
40%
Clinical Trials
800
Participants
200K
Comparative Safety Scale(Higher is safer)
Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
40
DangerousModerateSafe
Treatment Details
Time to Effect
Immediate hemodynamic improvement, symptomatic relief within weeks to months post-recovery
Treatment Duration
One-time procedure; valve durability 10-20+ years; initial procedure cost $25,000-$50,000.
Evidence Quality
HIGHNumber Needed to Treat (NNT)
2(Treat 2 patients to see 1 additional successful outcome)
Confidence Score
98%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$0
Monitoring:$1,500
Side Effect Mgmt:$1,200
Total Annual:$2,700
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
GOODICER
$70,000/QALY
QALYs Gained
1.6
Comparison vs Transcatheter Aortic Valve Replacement (TAVR)
Cost Difference
$-5,000/year
Less expensive
QALY Difference
-0.10 QALYs
Worse outcomes
Dominance
No dominance
Surgical Aortic Valve Replacement (SAVR) Outcomes
for Non-rheumatic calcific aortic valve disease
Efficacy Outcomes
Overall Effectiveness
+92%
Response Rate
+92%
Remission Rate
+99%
Common Side Effects
Major bleeding
+15%
Stroke
+2%
Acute kidney injury
+10%
Atrial fibrillation
+20%
Sternal wound infection
+3%
Prolonged recovery
+30%
WARNING: LIMITED TRIALS AVAILABLE
You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!
Active Clinical Trials
No active trials currently recruiting for this treatment
No active trials found in ClinicalTrials.gov